ZEMAIRA
NDC 0053-7202, .ALPHA.1-PROTEINASE INHIBITOR HUMAN, kit, from CSL Behring LLC.
- Product NDC
- 0053-7202
- Status
- Listed
- Labeler
- CSL Behring LLC
- Dosage form
- KIT
- Route
- —
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125078
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0053-7202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0053-7202-02 | 00053720202 | 1 KIT in 1 CARTON (0053-7202-02) * 76 mL in 1 VIAL, SINGLE-USE (0053-7212-01) * 76 mL in 1 VIAL, SINGLE-USE (0053-7653-80) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0053-7202
Use it
Look up 0053-7202 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0053-7202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0053-7202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.